MENU
OCT 13, 2021 10:30 AM PDT

Altered MicroRNA Expression in COVID-19 Patients Accurately Identifies of SARS-CoV-2 Infection

Sponsored by: QIAGEN
Speaker
  • Research Scientist, Host Response Team, Health and Biosecurity (H&B) at the Australian Centre for Disease Preparedness (ACDP) , CSIRO
    BIOGRAPHY

Abstract

By examining the host response to SARS-CoV-2 infection we gain valuable insights into viral pathogenesis and COVID-19 progression. MicroRNAs (miRNAs), a class of small (18-22nt), non-coding RNAs, often play central roles in the host-pathogen interface and have been recognised as promising biomarkers of infectious disease. In this study, we profiled the circulating miRNAs from 10 longitudinally sampled COVID-19 patients and their age and gender matched controls. We found 55 differentially expressed miRNAs in early-stage disease, including miRNAs with known pro- and anti-inflammatory roles. Machine learning also identified a three-miRNA signature of COVID-19 that predicted infection with 99.9% accuracy. This signature faded away as the patients recovered. When this three-miRNA signature was applied to ferrets (a common model of respiratory infections, including COVID-19), the signature predicted SARS-CoV-2 infection with 99.8% accuracy and could distinguish between SARS-CoV-2, influenza (H1N1), and uninfected controls with >95% accuracy.

This study demonstrates that SARS-CoV-2 infection results in a significant host miRNA response that aligns with our current knowledge of COVID-19 induced inflammation. By using a multivariate, machine learning approach, we have developed a robust miRNA biomarker signature of COVID-19. This signature could complement existing diagnostic tests by providing a new approach to detecting cases that might otherwise be missed. 


Show Resources
You May Also Like
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
Loading Comments...
Show Resources